Cell lines and primary breast cancers from humans contain negative CAV-1 RNA and protein levels, and CAV-1 reintroduced in vitro inhibits many tumorigenic properties, including anchorage independent growth (162). The gene discussed is CAV1; the disease is breast carcinoma.